東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Hematologic cancers = from molecular...

Tao, Jianguo.

Linked to FindBook

Google Book

Amazon

博客來

Hematologic cancers = from molecular pathobiology to targeted therapeutics /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Hematologic cancers/ edited by Jianguo Tao, Eduardo Sotomayor.{me_controlnum}
Reminder of title:	from molecular pathobiology to targeted therapeutics /
other author:	Tao, Jianguo.
Published:	Dordrecht :Springer Netherlands : : 2012.,
Description:	vi, 426 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Leukemia. -
Online resource:	http://dx.doi.org/10.1007/978-94-007-5028-9
ISBN:	9789400750289 (electronic bk.)

Hematologic cancers = from molecular pathobiology to targeted therapeutics /
Hematologic cancersfrom molecular pathobiology to targeted therapeutics /[electronic resource] :edited by Jianguo Tao, Eduardo Sotomayor.{me_controlnum} - Dordrecht :Springer Netherlands :2012. - vi, 426 p. :ill., digital ;24 cm. - Cancer growth and progression ;v.14. - Cancer growth and progression ;v.14..

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies.

ISBN: 9789400750289 (electronic bk.)Subjects--Topical Terms:

677274
Leukemia.

LC Class. No.: RC280.H47 / H46 2012

Dewey Class. No.: 616.99418

Hematologic cancers = from molecular pathobiology to targeted therapeutics /
LDR:02229nmm a2200277 a 4500 001 1329414
003 DE-He213
005 20121224134122.0
006 m d
007 cr nn 008maaau
008 130207s2012 ne s 0 eng d
020 $a 9789400750289 (electronic bk.)
020 $a 9789400750272 (paper)
035 $a 978-94-007-5028-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.H47 $b H46 2012
082 0 4 $a 616.99418 $2 23
090 $a RC280.H47 $b H487 2012
245 0 0 $a Hematologic cancers $h [electronic resource] : $b from molecular pathobiology to targeted therapeutics / $c edited by Jianguo Tao, Eduardo Sotomayor.{me_controlnum}
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2012.
300 $a vi, 426 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer growth and progression ; $v v.14
520 $a In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer, as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies.
650 0 $a Leukemia. $3 677274
650 0 $a Hematological oncology. $3 833892
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Hematology. $3 808260
650 2 4 $a Laboratory Medicine. $3 894271
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Apoptosis. $3 600650
650 2 4 $a Cell Biology. $3 892383
700 1 $a Tao, Jianguo. $3 1621246
700 1 $a Sotomayor, Eduardo. $3 1621247
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Cancer growth and progression ; $v v.14. $3 1621248
856 4 0 $u http://dx.doi.org/10.1007/978-94-007-5028-9
950 $a Medicine (Springer-11650)